Skip to main content

View full-text article in PMC

. 2018 Jul 5;48(4):410–422. doi: 10.1111/apt.14904

Table 6.

Post hoc analysis of the new catheter group^a

	History of CRBSIs			No history of CRBSIs
	2% Taurolidine (n = 18)	0.9% Saline (n = 9)	P value	2% Taurolidine (n = 18)	0.9% Saline (n = 26)	P value
CRBSIs—no.	3	4		0	9
Total treatment time—days	4992	1996		5256	6712
CRBSIs/1000 catheter days—(95% CI)	0.60 (0.12‐1.76)	2.00 (0.54‐5.13)	0.22	0 (0‐0)	1.34 (0.61‐2.55)	0.01

CI, confidence interval; CRBSI, catheter‐related bloodstream infection.

^a

P values were calculated with the use of Fisher's exact test from the website OpenEpi.20